Christopher A Czaja

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi Update on acute uncomplicated urinary tract infection in women
    Christopher A Czaja
    Department of Medicine, University of Washington School of Medicine, Seattle 98195, USA
    Postgrad Med 119:39-45. 2006
  2. ncbi Population-based epidemiologic analysis of acute pyelonephritis
    Christopher A Czaja
    Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA
    Clin Infect Dis 45:273-80. 2007
  3. ncbi Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection
    Ann E Stapleton
    Department of Medicine, University of Washington, Seattle, 98195, USA
    Clin Infect Dis 52:1212-7. 2011
  4. ncbi Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women
    Christopher A Czaja
    Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, WA 98195, USA
    Infect Dis Obstet Gynecol 2007:35387. 2007

Detail Information

Publications4

  1. ncbi Update on acute uncomplicated urinary tract infection in women
    Christopher A Czaja
    Department of Medicine, University of Washington School of Medicine, Seattle 98195, USA
    Postgrad Med 119:39-45. 2006
    ..Treatment of UTI has become more difficult because of the rising levels of resistance to commonly used antibiotics. Further research is needed to develop new antibiotic therapies and nonantibiotic prevention measures...
  2. ncbi Population-based epidemiologic analysis of acute pyelonephritis
    Christopher A Czaja
    Division of Allergy and Infectious Diseases, University of Washington, Seattle, WA 98195, USA
    Clin Infect Dis 45:273-80. 2007
    ..We performed a population-based analysis of trends in the incidence, microbial etiology, antimicrobial resistance, and antimicrobial therapy of outpatient and inpatient pyelonephritis...
  3. ncbi Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection
    Ann E Stapleton
    Department of Medicine, University of Washington, Seattle, 98195, USA
    Clin Infect Dis 52:1212-7. 2011
    ..We conducted a double-blind placebo-controlled trial of a Lactobacillus crispatus intravaginal suppository probiotic (Lactin-V; Osel) for prevention of recurrent UTI in premenopausal women...
  4. ncbi Phase I trial of a Lactobacillus crispatus vaginal suppository for prevention of recurrent urinary tract infection in women
    Christopher A Czaja
    Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, WA 98195, USA
    Infect Dis Obstet Gynecol 2007:35387. 2007
    ..We performed a phase I trial to assess the safety and tolerance of a Lactobacillus vaginal suppository for prevention of recurrent UTI...